Peter M. Voorhees
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 145
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 31
- CAR-T cell therapy research 15
- Molecular Biology top 2%
- Protein Degradation and Inhibitors 59
- Ubiquitin and proteasome pathways 21
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 31
- Immunology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 29
-
- Lymphoma Diagnosis and Treatment 12
- Co-authors
- Robert Z. OrlowskiDeborah J. KuhnPaul G. RichardsonSaad Z. UsmaniQing ChenElizabeth Claire DeesBert H. O’NeilSagar Lonial
- Cited by
- HematologyOncologyMolecular Biology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (26 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Peter M. Voorhees
163 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Hematology 2.9k
- Oncology 2.7k
- Molecular Biology 3.3k
- Genetics 474
- Immunology 600
Countries citing papers authored by Peter M. Voorhees
This map shows the geographic impact of Peter M. Voorhees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Voorhees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Voorhees more than expected).
Fields of papers citing papers by Peter M. Voorhees
This network shows the impact of papers produced by Peter M. Voorhees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Voorhees. The network helps show where Peter M. Voorhees may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter M. Voorhees, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 84 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 15 | |
| 15 | 2019 | 11 | |
| 16 | 2019 | 15 | |
| 17 | 2017 | 0 | |
| 18 | 2013 | 166 | |
| 19 | 2008 | 27 | |
| 20 | 2007 | 93 |
About Peter M. Voorhees
Peter M. Voorhees is a scholar working on Hematology, Genetics and Oncology, having authored 172 papers that have together received 5.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (145 papers), Protein Degradation and Inhibitors (59 papers), Chronic Lymphocytic Leukemia Research (31 papers), Peptidase Inhibition and Analysis (31 papers), Monoclonal and Polyclonal Antibodies Research (29 papers), Ubiquitin and proteasome pathways (21 papers), CAR-T cell therapy research (15 papers) and Lymphoma Diagnosis and Treatment (12 papers). The work is most often cited by research in Hematology (2.9k citations), Oncology (2.7k citations) and Molecular Biology (3.3k citations). Peter M. Voorhees has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert Z. Orlowski, Deborah J. Kuhn, Paul G. Richardson, Saad Z. Usmani, Qing Chen, Elizabeth Claire Dees, Bert H. O’Neil, Sagar Lonial, John S. Strader and Asher Chanan‐Khan. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.